Prevalence and management of hypertension in acute coronary syndrome patients varies by sex: Observations from the Sibrafiban versus aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes (SYMPHONY) randomized clinical trials

This publication has 39 references indexed in Scilit:

• Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
  The Lancet, 2004
• A Calcium Antagonist vs a Non–Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery Disease
  JAMA, 2003
• Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
  Hypertension, 2003
• Predictors of 90-day outcome in patients stabilized after acute coronary syndromes
  Published by Oxford University Press (OUP) ,2003
• Residual Lifetime Risk for Developing Hypertension in Middle-aged Women and Men
  JAMA, 2002
• Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: Results from the NHLBI WISE study
  American Heart Journal, 2001
• Hypertension in women
  Journal of Human Hypertension, 2000
• The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI
  JAMA, 2000
• Statement from the National High Blood Pressure Education Program: prevalence of hypertension
  American Journal of Hypertension, 2000
• Predictors of 30-Day Mortality in the Era of Reperfusion for Acute Myocardial Infarction
  Circulation, 1995